Histopathology of the gastric oxyntic mucosa in two different patient groups during long-term treatment with omeprazole

Keyphrases

• Long-term Treatment 100%
• Omeprazole 100%
• Zollinger-Ellison Syndrome 100%
• Progressive Systemic Sclerosis 100%
• Oxyntic mucosa 100%
• Enterochromaffin Cells 80%
• Gastrin 60%
• Cell Changes 60%
• Parietal Cell 60%
• Hypergastrinemia 40%
• Helicobacter Pylori Infection 40%
• Hyperplasia 40%
• Micronodular 40%
• Inflammation 20%
• Treatment Duration 20%
• Histology 20%
• Cell-to-cell 20%
• Cell Proliferation 20%
• Neoplasia 20%
• Gastric mucosa 20%
• Gastric mucosal 20%
• Mucosal Inflammation 20%
• Acid Inhibition 20%
• Infectious Dose 20%
• Gastroesophageal Reflux Disease 20%
• Dose Duration 20%
• Carcinoid 20%
• Enterochromaffin-like Cell Hyperplasia 20%
• Duration of Infection 20%
• Chronic Gastritis 20%
• 24-h pH-metry 20%
• Acid Hypersecretion 20%
• Hypochlorhydria 20%
• Basal Acid Output 20%
• Esophageal pH 20%
• MEN1 Syndrome 20%
• Endoscopy Biopsy 20%

Medicine and Dentistry

• Histopathology 100%
• Mucosa 100%
• Omeprazole 100%
• Systemic Scleroderma 100%
• Zollinger-Ellison Syndrome 100%
• Enterochromaffin Like Cell 100%
• Stomach Parietal Cell 60%
• Hyperplasia 40%
• Hypergastrinemia 40%
• Gastrin 40%
• Biopsy 20%
• Infection 20%
• Neoplasm 20%
• Endoscopy 20%
• Cell Proliferation 20%
• Treatment Duration 20%
• Carcinoid 20%
• Cell Hyperplasia 20%
• Helicobacter Infection 20%
• Pylorus 20%
• Stomach Mucosa 20%
• Gastroesophageal Reflux 20%
• Gastric Hypoacidity 20%
• Gastrin Release 20%
• Chronic Gastritis 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Omeprazole 100%
• Systemic Sclerosis 100%
• Zollinger Ellison Syndrome 100%
• Gastrin 60%
• Inflammation 40%
• Hyperplasia 40%
• Hypergastrinemia 40%
• Syndrome 20%
• Neoplasm 20%
• Infection 20%
• Helicobacter Infection 20%
• Gastric Mucosa 20%
• Gastroesophageal Reflux 20%
• Cell Hyperplasia 20%
• Carcinoid 20%
• Chronic Gastritis 20%
• Gastric Hypoacidity 20%